NGeneBio Co., Ltd.

₩741.00As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:354200Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (53.93%)
Div yield —
ROE (26.81%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.96
PE TTM —
TSR TTM (80.17%)
Mkt cap ₩11.92B
ROIC (9.84%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩814
9.82%
(45.67%)
Hold 3|6|7|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
6.38
6.17
6.86
7.57
7.67%
2.02%
4.26%
20.04%
Revenue₩B
1.581
1.649
1.731
1.782
17.07%
19.61%
20.20%
17.14%
Peers (US$8.788M)
Cap (US$)
PE
14.83M
—
10.74M
—
Capital
TTM
5Y
10Y
Leveragex
0.563
(0.217)
(0.204)
EBIT/Intx
0.061
1.276
1.083
Own earn%
(35.97)
(191.95)
(157.53)
Sh yield%
31.41
3.02
5.76
Owners
Insiders/Inst%
8.07
21.49
Short interest%
5.86
SBC / revenue%
1.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
3–11
$1 testx
0.1
Incr. ROIC%
6